NeuroThera Labs to Acquire Majority Stake in CliniQuantum

NeuroThera Labs, a subsidiary of SciSparc that holds 75%, has signed a definitive agreement to acquire a majority stake in CliniQuantum, a company focused on quantum-based clinical trials. The deal is structured as an add-on acquisition.

The announcement does not disclose the purchase price or the percentage of the stake beyond “majority.”